Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
J Immunol. 2011 Jan 15;186(2):1044-59. doi: 10.4049/jimmunol.1003052. Epub 2010 Dec 13.
Intravenous administration of a novel recombinant rhesus mAb against the α4β7 gut-homing integrin (mAb) into rhesus macaques just prior to and during acute SIV infection resulted in significant decrease in plasma and gastrointestinal (GI) tissue viral load and a marked reduction in GI tissue proviral DNA load as compared with control SIV-infected rhesus macaques. This mAb administration was associated with increases in peripheral blood naive and central memory CD4(+) T cells and maintenance of a high frequency of CCR5(+)CD4(+) T cells. Additionally, such mAb administration inhibited the mobilization of NK cells and plasmacytoid dendritic cells characteristically seen in the control animals during acute infection accompanied by the inhibition of the synthesis of MIP-3α by the gut tissues. These data in concert suggest that blocking of GI trafficking CD4(+) T cells and inhibiting the mobilization of cell lineages of the innate immune system may be a powerful new tool to protect GI tissues and modulate acute lentiviral infection.
静脉注射一种新型重组恒河猴针对 α4β7 肠道归巢整合素(mAb)进入恒河猴在急性 SIV 感染前和期间导致显著减少血浆和胃肠道(GI)组织病毒载量和明显减少 GI 组织前病毒 DNA 载量与对照 SIV 感染的恒河猴相比。这种 mAb 给药与外周血幼稚和中央记忆 CD4(+)T 细胞的增加以及 CCR5(+)CD4(+)T 细胞的高频率维持有关。此外,这种 mAb 给药抑制了 NK 细胞和浆细胞样树突状细胞的动员,这些细胞在急性感染期间在对照动物中典型地出现,同时抑制了肠道组织中 MIP-3α 的合成。这些数据表明,阻断 GI 归巢 CD4(+)T 细胞和抑制先天免疫系统细胞谱系的动员可能是保护 GI 组织和调节急性慢病毒感染的一种强大的新工具。